Literature DB >> 32114329

Comparison of timeline follow-back self-report and oral fluid testing to detect substance use in adult primary care patients.

Courtney D Nordeck1, Jan Gryczynski2, Kevin E O'Grady3, Kathryn Polak4, Dace S Svikis4, Jennifer McNeely5, Li-Tzy Wu6, Robert P Schwartz2.   

Abstract

BACKGROUND: Timeline Follow-back (TLFB) interviews using self-report are often used to assess substance use. Oral fluid testing (OFT) offers an objective measure of substance use. There are limited data on the agreement between TLFB and OFT.
METHODS: In this secondary analysis from a multisite study in five primary care sites, self-reported TLFB and OFT data collected under confidential conditions were compared to assess concordance (N=1799). OFT samples were analyzed for marijuana, heroin, cocaine, and non-medical use of prescription opioids. Demographic differences in discordance relative to TLFB and OFT concordant results for marijuana, the only substance with an adequate sample size in this analysis, were examined using multinomial logistic regression.
RESULTS: Overall concordance rates between TLFB and OFT were 94.9 % or higher for each substance, driven by large subgroups with no use. Among participants with discordant use, marijuana was the only substance with lower detection on OFT than self-report (27.6 % OFT-positive only vs 32.2 % TLFB-positive only), whereas cocaine (65.6 % vs 8.6 %), prescription opioids (90.4 % vs 6.0 %), and heroin (40.7 % vs 26.0 %) all had higher detection via OFT than TLFB. Participants who reported marijuana use but had a negative OFT were more likely to be younger, Hispanic, and White compared to those with TLFB and OFT concordant positive results.
CONCLUSIONS: TLFB and OFT show disparate detection of different substances. Researchers should consider the implications of using either self-report or oral fluid testing in isolation, depending on the substance and collection setting. Triangulating multiple sources of information may improve detection of drug use.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Concordance; Discordance; Illicit drug use; Oral fluid testing; Primary care; Self-Report; Timeline follow-back

Mesh:

Year:  2020        PMID: 32114329      PMCID: PMC7360056          DOI: 10.1016/j.drugalcdep.2020.107939

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  20 in total

1.  Comparisons of self-report data and oral fluid testing in detecting drug use amongst new treatment clients.

Authors:  Joanne Neale; Michele Robertson
Journal:  Drug Alcohol Depend       Date:  2003-07-20       Impact factor: 4.492

Review 2.  Validity of Timeline Follow-Back for self-reported use of cannabis and other illicit substances--systematic review and meta-analysis.

Authors:  Carsten Rygaard Hjorthøj; Anne Rygaard Hjorthøj; Merete Nordentoft
Journal:  Addict Behav       Date:  2011-11-26       Impact factor: 3.913

Review 3.  Interpretation of oral fluid tests for drugs of abuse.

Authors:  Edward J Cone; Marilyn A Huestis
Journal:  Ann N Y Acad Sci       Date:  2007-03-01       Impact factor: 5.691

4.  What's the agreement between self-reported and biochemical verification of drug use? A look at permanent supportive housing residents.

Authors:  Alexis Rendon; Melvin Livingston; Sumihiro Suzuki; Whitney Hill; Scott Walters
Journal:  Addict Behav       Date:  2017-02-10       Impact factor: 3.913

Review 5.  Self-report among injecting drug users: a review.

Authors:  S Darke
Journal:  Drug Alcohol Depend       Date:  1998-08-01       Impact factor: 4.492

Review 6.  Testing for drugs of abuse in saliva and sweat.

Authors:  D A Kidwell; J C Holland; S Athanaselis
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1998-08-21

Review 7.  The validity of self-reported drug use in survey research: an overview and critique of research methods.

Authors:  L Harrison
Journal:  NIDA Res Monogr       Date:  1997

8.  The reliability of the Alcohol Timeline Followback when administered by telephone and by computer.

Authors:  L C Sobell; J Brown; G I Leo; M B Sobell
Journal:  Drug Alcohol Depend       Date:  1996-09       Impact factor: 4.492

Review 9.  Saliva testing for drugs of abuse.

Authors:  E J Cone
Journal:  Ann N Y Acad Sci       Date:  1993-09-20       Impact factor: 5.691

10.  Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients.

Authors:  Jennifer McNeely; Li-Tzy Wu; Geetha Subramaniam; Gaurav Sharma; Lauretta A Cathers; Dace Svikis; Luke Sleiter; Linnea Russell; Courtney Nordeck; Anjalee Sharma; Kevin E O'Grady; Leah B Bouk; Carol Cushing; Jacqueline King; Aimee Wahle; Robert P Schwartz
Journal:  Ann Intern Med       Date:  2016-09-06       Impact factor: 25.391

View more
  3 in total

1.  Electronic health record data may lead to underestimates of cannabis use-Especially among older populations.

Authors:  Joseph J Palamar; Austin Le
Journal:  J Am Geriatr Soc       Date:  2022-03-02       Impact factor: 7.538

2.  Cannabis use, comorbidities, and prescription medication use among older adults in a large healthcare system in Los Angeles, CA 2019-2020.

Authors:  Marjan Javanbakht; Sae Takada; Whitney Akabike; Steve Shoptaw; Lillian Gelberg
Journal:  J Am Geriatr Soc       Date:  2022-03-02       Impact factor: 7.538

3.  What is the prevalence of drug use in the general population? Simulating underreported and unknown use for more accurate national estimates.

Authors:  Natalie S Levy; Joseph J Palamar; Stephen J Mooney; Charles M Cleland; Katherine M Keyes
Journal:  Ann Epidemiol       Date:  2022-01-03       Impact factor: 6.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.